Copyright
©The Author(s) 2022.
World J Transplant. Mar 18, 2022; 12(3): 27-41
Published online Mar 18, 2022. doi: 10.5500/wjt.v12.i3.27
Published online Mar 18, 2022. doi: 10.5500/wjt.v12.i3.27
Figure 4 Drugs acting at different levels to control the antibody formation.
BLyS: B Lymphocyte stimulating factor; mAb: Monoclonal antibody; C1-INH: C1 inhibitors; NK: Natural killer; Cp: Complement; FcyR: FcyReceptor; MAC: Membrane attacking complex; MHC: Major histocompatibility complex; IL: Interleukin.
- Citation: Salvadori M, Tsalouchos A. Innovative immunosuppression in kidney transplantation: A challenge for unmet needs. World J Transplant 2022; 12(3): 27-41
- URL: https://www.wjgnet.com/2220-3230/full/v12/i3/27.htm
- DOI: https://dx.doi.org/10.5500/wjt.v12.i3.27